scispace - formally typeset
G

Giovanni F.M. Strippoli

Researcher at University of Sydney

Publications -  318
Citations -  19179

Giovanni F.M. Strippoli is an academic researcher from University of Sydney. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 71, co-authored 298 publications receiving 16385 citations. Previous affiliations of Giovanni F.M. Strippoli include University of Catania & University of Eastern Piedmont.

Papers
More filters
Journal ArticleDOI

Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.

TL;DR: MMF is as effective as cyclophosphamide in achieving remission in lupus nephritis, but is safer, with a lower risk of ovarian failure, and more effective than azathioprine in maintenance therapy for preventing relapse, with no difference in clinically important side effects.
Journal ArticleDOI

Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials.

TL;DR: The trials were inadequately powered to show a reduction in risk for fracture and Bisphosphonates and vitamin D have a beneficial effect on BMD at the lumbar spine and femoral neck.
Journal ArticleDOI

Haemodiafiltration, haemofiltration and haemodialysis for end‐stage kidney disease

TL;DR: Convective dialysis therapies (HDF and HF) are associated with lower mortality compared to diffusive therapy (HD) in observational studies as discussed by the authors, but results across very heterogeneous analyses were insufficient to assess all risks and low-level clinical outcomes.
Journal ArticleDOI

Glucose targets for preventing diabetic kidney disease and its progression

TL;DR: Moderate confidence is had in the effects of glucose lowering strategies on ESKD, all-cause mortality, myocardial infarction, and progressive protein leakage by kidney disease and low or very low confidence in effects of treatment on death related to cardiovascular complications and doubling of serum creatinine.
Journal ArticleDOI

The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.

TL;DR: On-line HF may improve survival independent of Kt/V in patients with ESRD, with a significant decrease in plasma beta(2)-microglobulin levels and increased body mass index.